Log In
BCIQ
Print this Print this
 

VeX-HIV

  Manage Alerts
Collapse Summary General Information
Company Population Genetics Technologies Ltd.
DescriptionHIV-1 drug resistance diagnostic test targeting all major HIV-1 subtypes using VeriTag next generation sequencing technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationInfectious, Diagnostic
Indication DetailsDetermine HIV drug resistance for use in the clinical management of HIV positive patients.
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/12/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today